Naringenin inhibits pro‑inflammatory cytokine production in macrophages through inducing MT1G to suppress the activation of NF‑κB

Bodet, 2008, Naringenin has anti-inflammatory properties in macrophage and ex vivo human whole-blood models, J. Periodont. Res., 43, 400, 10.1111/j.1600-0765.2007.01055.x

Chen, 2014, Mucoactive effects of naringin in lipopolysaccharide-induced acute lung injury mice and beagle dogs, Environ. Toxicol. Pharmacol., 38, 279, 10.1016/j.etap.2014.04.030

Chen, 2018, Inflammatory responses and inflammation-associated diseases in organs, Oncotarget, 9, 7204, 10.18632/oncotarget.23208

Coyle, 2002, Rofe AM. Metallothionein: the multipurpose protein, Cell. Mol. Life Sci., 59, 627, 10.1007/s00018-002-8454-2

de Oliveira, 2018, Naringenin exerts anti-inflammatory effects in paraquat-treated SH-SY5Y cells through a mechanism associated with the Nrf2/HO-1 axis, Neurochem. Res., 43, 894, 10.1007/s11064-018-2495-x

Dou, 2013, Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-kappaB signalling, Br. J. Nutr., 110, 599, 10.1017/S0007114512005594

Ferrero-Miliani, 2007, Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation, Clin. Exp. Immunol., 147, 227, 10.1111/j.1365-2249.2006.03261.x

Fukada, 2011, Zinc homeostasis and signaling in health and diseases: zinc signaling, J. Biol. Inorg. Chem., 16, 1123, 10.1007/s00775-011-0797-4

Gu, 2017, Metallothionein is downstream of Nrf2 and partially mediates sulforaphane prevention of diabetic cardiomyopathy, Diabetes, 66, 529, 10.2337/db15-1274

Guha, 2001, LPS induction of gene expression in human monocytes, Cell. Signal., 13, 85, 10.1016/S0898-6568(00)00149-2

Haase, 2014, Zinc signals and immune function, BioFactors, 40, 27, 10.1002/biof.1114

Huang, 2019, Naringenin attenuates carotid restenosis in rats after balloon injury through its anti-inflammation and anti-oxidative effects via the RIP1-RIP3-MLKL signaling pathway, Eur. J. Pharmacol., 855, 167, 10.1016/j.ejphar.2019.05.012

Imoto, 2010, Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells, J. Biol. Chem., 285, 10300, 10.1074/jbc.M109.095810

Inoue, 2009, Metallothionein as an anti-inflammatory mediator, Mediators Inflamm., 2009, 10.1155/2009/101659

Ji, 2009, Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia?, EMBO Rep., 10, 194, 10.1038/embor.2009.12

Jin, 2017, Naringenin ameliorates acute inflammation by regulating intracellular cytokine degradation, J. Immunol., 199, 3466, 10.4049/jimmunol.1602016

Kim, 2003, Zinc-induced NF-kappaB inhibition can be modulated by changes in the intracellular metallothionein level, Toxicol. Appl. Pharmacol., 190, 189, 10.1016/S0041-008X(03)00167-4

Laity, 2007, Understanding the mechanisms of zinc-sensing by metal-response element binding transcription factor-1 (MTF-1), Arch. Biochem. Biophys., 463, 201, 10.1016/j.abb.2007.03.019

Lappas, 2018, Expression and regulation of metallothioneins in myometrium and fetal membranes, Am. J. Reprod. Immunol., 80, 10.1111/aji.13040

Lawrence, 2009, The nuclear factor NF-kappaB pathway in inflammation, Cold Spring Harb. Perspect. Biol., 1, 10.1101/cshperspect.a001651

Liu, 2016, The citrus flavonoid naringenin confers protection in a murine endotoxaemia model through AMPK-ATF3-dependent negative regulation of the TLR4 signalling pathway, Sci. Rep., 6, 39735, 10.1038/srep39735

Liu, 2018, Naringenin attenuates inflammation in chronic obstructive pulmonary disease in cigarette smoke induced mouse model and involves suppression of NF-kappaB, J. Microbiol. Biotechnol.

Maret, 2011, Redox biochemistry of mammalian metallothioneins, J. Biol. Inorg. Chem., 16, 1079, 10.1007/s00775-011-0800-0

Medzhitov, 2008, Origin and physiological roles of inflammation, Nature, 454, 428, 10.1038/nature07201

Patel, 2018, A review on pharmacological and analytical aspects of naringenin, Chin. J. Integr. Med., 24, 551, 10.1007/s11655-014-1960-x

Rajappa, 2018, Treatment with naringenin elevates the activity of transcription factor Nrf2 to protect pancreatic beta-cells from streptozotocin-induced diabetes in vitro and in vivo, Front. Pharmacol., 9, 1562, 10.3389/fphar.2018.01562

Salehi, 2019, The therapeutic potential of naringenin: a review of clinical trials, Pharmaceuticals, 12

Sato, 2015, The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus, Immunity, 42, 123, 10.1016/j.immuni.2014.12.016

Vafeiadou, 2009, The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury, Arch. Biochem. Biophys., 484, 100, 10.1016/j.abb.2009.01.016

Yu, 2015, Protective effect of naringenin against lipopolysaccharide-induced injury in normal human bronchial epithelium via suppression of MAPK signaling, Inflammation, 38, 195, 10.1007/s10753-014-0022-z

Zeng, 2018, Naringenin as a potential immunomodulator in therapeutics, Pharmacol. Res., 135, 122, 10.1016/j.phrs.2018.08.002